CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells (Q78404465)
Jump to navigation
Jump to search
scientific article published on 01 November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells |
scientific article published on 01 November 2002 |
Statements
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells (English)
Hong-Ming Hu
Hauke Winter
Jun Ma
Michael Croft
Walter J Urba
1 November 2002